Digital PCR Market Size to Hit USD 18.78 Billion at a 9.0% CAGR from 2024 to 2032- Report by Polaris Market Research (PMR)
The market is significantly expanding due to the rising number of research and development activities along with growing cancer cases.
New York, USA, Aug. 12, 2024 (GLOBE NEWSWIRE) — Market Overview:
The value of the global digital PCR market was USD 8.64 billion in 2023. The market is expected to rise from USD 9.40 billion in 2024 to USD 18.78 billion by 2032, with a robust CAGR of 9.0% during the forecast period of 2024 – 2032.
Market Introduction:
What Is Digital PCR?
Digital PCR, also known as dPCR, is a specialized technique for the detection and qualification of target nucleic acids. It leverages the same fundamental chemistry as qPCR. However, unlike qPCR, dPCR data is collected at the endpoint of the reaction. Before the amplification process, the PCR reaction made up of template nucleic acids, primers, enzymes, and market mix is divided into thousands of microreactions.
The amplification process is performed separately on each microreaction, which effectively comprises zero, one, or a relatively small amount of target nucleic acid molecules. Microreactions with the target will display post-amplification fluorescence, whereas those without the target will not. This precision is a key advantage of digital PCR, making it less prone to inhibitors, errors, and amplification biases compared to conventional PCR methods.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/digital-pcr-market/request-for-sample
Digital PCR Report Attributes:
| Report Attributes | Details |
| Market value in 2023 | USD 8.64 billion |
| Market value in 2032 | USD 18.78 billion |
| CAGR | 9.0% from 2024 – 2032 |
| Base year | 2023 |
| Historical data | 2019 – 2022 |
| Forecast Period | 2024 – 2032 |
Key Highlights of the Report:
- The launch of new products, a rise in acquisitions, the increased adoption of technology by laboratories, and the rising incidence of infectious diseases, cancer, and genetic abnormalities are some of the major factors anticipated to propel the market expansion during the forecast period.
- The market is segmented based on product type, capacity, automation, end-user, and region.
- North America accounts for the largest digital PCR market share during the forecast period.
Market Key Players:
- Avance Biosciences
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd.
- JN Medsys
- Precigenome LLC.
- QIAGEN
- Standard BioTools Inc.
- Stilla
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
Request for a Discount on this Report Before Purchase:
Top Market Developments:
Growth Drivers And Trends:
- R&D Initiatives and Investments: Ongoing research and development activities aimed at producing advanced digital PCR systems integrated with enhanced efficiency, accuracy, and speed are expected to augment the digital PCR market growth. These R&D efforts prefer improving assay sensitivity, automation, and multiplexing capabilities in order to cater to the rising demand for higher precision and throughput.
- Technological Developments: Continuous advancements in digital PCR technologies, which excel in accuracy in detecting genetic mutations, rare sequences, and low-abundance targets in both genetic mutations, rare sequences, and low-abundance targets, is the next key factor driving the digital PCR market CAGR.
- Product Launches: A growing number of product launches in the global market are likely to uplift the market expansion. For instance, in June 2021, a key firm in the life sciences field, Bio-Rad Laboratories, Inc., launched its PREvalence ddPCR SARS-CoV-2 wastewater quantification kit, initially made for COVID-19 wastewater testing.
- Rising Cancer Cases: Digital PCR has the potential to detect rare mutations and monitor disease progression in the treatment of diseases such as lung cancer, blood cancer, and brain tumors with great precision. As a result, the market for digital PCR is significantly growing due to the rising demand for accurate and early cancer detection.
Which Region Leads The Digital PCR?
- North America: By region, North America has the largest market share owing to the well-developed healthcare infrastructure, which incorporates advanced technologies like PCR. In addition, diagnostic laboratories and research institutions in the region are employing advanced tools and resources to reinforce their research capabilities in technologies. Further, prominent market companies are putting efforts into strengthening their presence and catering requirements in North America, fueling the regional digital PCR market demand over the foreseen period.
- Asia Pacific: The country is expected to record the highest CAGR throughout the forecast period because many countries in the Asia Pacific are raising their healthcare funds. Additionally, growing investments by governments in advanced healthcare technologies like molecular diagnostics for the enhancement of healthcare infrastructure and patient outcomes further fuel the digital PCR industry growth.
Inquire more about this report before purchase:
https://www.polarismarketresearch.com/industry-analysis/digital-pcr-market/inquire-before-buying
Segmental Overview:
Digital PCR Product Offering Outlook
- Reagent & Consumables
- Instruments
- Software
- Services
Digital PCR Technology Outlook
- Droplet Digital PCR
- Beaming Digital PCR
Digital PCR Application Outlook
- Clinical Applications
- Research Applications
- Forensic Applications
- Environmental Applications
- Other Applications
Digital PCR, End User Outlook
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- CROs and CDMOs
- Forensic Laboratories
- Other End Users
Digital PCR Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia-Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Browse More Research Reports:
Healthcare Data Integration Market
Advanced Therapy Medicinal Products CDMO Market
About Polaris Market Research:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.
Contact:
Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
